Getinge AB Class B · OMXSTO:GETI_B
Getinge AB Class B — Q4 2001 Earnings Presentation
29 slides from Getinge AB Class B's earnings presentation, 2002
Slide 1: GETINGE
GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled people Customers Acute Care Long term care Industry/Laboratories Net Sales 8 billion SEK Associates 5 300 Manufacturing 20 production units in
Slide 2: Business Scope
Business Scope Extended Care Areas Business Areas Infection Control Hygiene Systems Surgical Systems Sterilisation Patient Handling Surgical tables Business Disinfection Wound Care Surgical lamps 40% 30% 30% segments Customer segments Industry Acute care Long term care I0% 60% 30% Customer
Slide 3: Business Area Extended Care
Business Area Extended Care Hygiene Systems Wound Care Patient Handling Complete solutions for institutional extended care: Nursing Homes, Hospitals, Assisted Living
Slide 4: Extended Care
Extended Care Hygiene Systems Patient Handling Wound Care Market: 1 400 MSEK 1 700 MSEK 8 000 MSEK Growth: 5 - 7 % 8 - 10 % 8 - 10 %
Slide 5: Extended Care Strategic Corner-Stones
Extended Care Strategic Corner-Stones Product leadership Complete Solutions Positive outcomes
Slide 6: Business Area Extended Care 2001-2002
Business Area Extended Care 2001- 2002 A well-positioned business area with increased focus on growth Strong product pipeline Cross-selling wound care Expansion sales staff
Slide 7: Extended Care Market development Q4
Extended Care Market development Q4 (msek) 2 001 2 000 Change 2 001 2 000 Change per market Q4 Q4 12 Mon 12 Mon USA and Canada 256 214 19% 963 771 25% Great Britain 203 171 19% 737 569 30% Germany 65 60 7% 272 237 14% Other W Europe 168 159 5% 579 478 21% Rest of the world 27 23 17% 93 84 12% Busine
Slide 8: Extended Care Results Q4
Extended Care Results Q4 (msek) 2001 2000 2001 2000 Q4 Q 4 12 Mon 12 Mon Net sales 762 634 2 656 2 111 Gross margin % 49,8% 49,5% 49,2% 49,4% Operating cost -241 -199 -886 -719 Operating profit 139 115 421 323 Operating margin % 18,2% 18,2% 15,9% 15,3%
Slide 9: Infection Control - Health Care
Infection Control - Health Care Disinfection Sterilization IT-solutions Load handling Complete Systems for: Central Processing Departments, Outpatient Surgery, Wards, Infectious Waste, Microbiology, Pharmacies
Slide 10: Infection Control - Industry
Infection Control - Industry Sterilization Washing Water Treatment Load Handling Complete Systems for: Production, Research / Laboratories, Animal Care Facilities, Food Industry
Slide 11: Infection Control
Infection Control Sterilization Disinfection Market: 6 200 MSEK 2 500 MSEK Growth: 4% 5%
Slide 12: Infection Control Health Care
Infection Control Health Care From Product to Solution Sterilizer Disinfector Load handling Complete Logistics Infection Information management Control Consumables After Sales service Solutions Education From Cost to Revenue
Slide 13: Infection Control Strategic Corner-Stones
Infection Control Strategic Corner-Stones Cost Leadership Complete Solutions Service Infrastructure
Slide 14: Infection Control 2001-2002
Infection Control 2001- 2002 To create a homogeneous and market oriented organization from a federation of companies acquired in the last I0 years Improved production structure - cost leadership System sales Service expansion - infrastructure
Slide 15: Infection Control Market development Q4
Infection Control Market development Q4 (msek) 2001 2000 Change 2001 2000 Change per market Q4 Q4 12 Mon 2 Mon Western Europe 406 352 15% 1 465 1 271 15% USA and Canada 425 310 37% 1 451 1 170 24% Asia/Australia 95 66 44% 326 265 23% Rest of the world 71 44 62% 162 181 -10% Business area total 996 7
Slide 16: Infection Control Results Q4
Infection Control Results Q4 (msek) 2001 2000 2001 2000 Q4 Q 4 12 Mon 12 Mon Net sales 1 040 947 3 204 2 935 Gross margin % 39,2% 38,5% 36,0% 37,2% Operating cost -249 -209 -833 -722 Operating profit 159 156 321 369 Operating margin % 15,3% 16,5% 10,0% 12,6%
Slide 17: Business Area Surgical Systems
Business Area Surgical Systems The infection control market and the market for surgical systems is converging Getinge will become a more attractive and competent supplier to the healthcare industry The market for Surgical Systems is to a large extent a fragmented market with further opportunities
Slide 18: Surgical Systems
Surgical Systems Surgical Tables Surgical Lights Ceiling Service Systems Integrated Solutions for Surgical Workstations and ICU’s
Slide 19: Surgical Systems: Maquet
Surgical Systems Maquet was acquired in December 2000 Net sales Appr. I 400 Msek Employees I 300 Products Surgical tables Infection Control Distribution Own sales companies in Germany, UK, Italy, France, Belgium Japan, USA Distributors and agents in 90 countries
Slide 20: Surgical Systems: ALM
Surgical Systems ALM was acquired in January 2001 Net sales Appr. 660 Msek Employees 300 Products Surgical lights Surgical tables Ceiling Service Units Distribution Own sales companies in UK, US, France, Italy, Spain and China Distributors and agents in more than 50 countries
Slide 21: Business Area Surgical Systems: A First Step
Business Area Surgical Systems A First Step To create a strong global player in the surgical field with world leadership positions in: - Surgical tables - Surgical lights - Ceiling Service Units Distributed through own sales organisations in all major developed markets
Slide 22: Surgical Systems
Surgical Systems Surgical tables Surgical lights Ceiling Service Units Market: 4 000 M 2 000 M 1 000 M Growth: 5% 5% 10 - 15%
Slide 23: Synergies Surgical Systems
Synergies Surgical Systems Cost synergies of SEK I40 - I50 million annually Cross-selling => increased sales growth in the years 2 - 5 Closing down OrtoMaquet will improve the operating profit by sek 65 million annually
Slide 24: Surgical Systems Growth Opportunities
Surgical Systems Growth Opportunities Continuous growth through acquisition principally lights and ceiling service units Develop strong cross selling capabilities Evaluate new areas of interest in the Surgical systems environment Product innovation - IGS - Endoscopy - Integrated surgical workpla
Slide 25: Surgical Systems Market development Q4
Surgical systems Market development Q4 (msek) 2001 2000 2001 per market Q4 Q4 12 Mon USA and Canada 135 44 428 Great Britain 25 0 116 Germany 127 0 591 Other Western Europe 184 2 621 Rest of the world 112 0 507 Business area total 583 45 2 263
Slide 26: Surgical Systems Results Q4
Surgical systems Results Q4 (msek) 2001 2000 2001 2000 Q4 Q4 12 Mon 12 Mon Net sales 635 37 2 223 147 Gross margin % 51,7% 39,1% 49,9% 30,3% Operating cost -253 -9 -880 -45 Operating profit 76 5 228 -1 Operating margin % 11,9% 13,9% 10,3% -0,7%
Slide 27: Getinge Group Objectives
Getinge Group Objectives To retain and develop world leadership position in prioritized business areas / business niches Growth in profit before tax of I5% over a business cycle Organic growth 5 % Internally generated cash flow to sustain an external growth rate of I0 %
Slide 28: Getinge AB Results
Getinge AB Results (Msek) 2001 2000 Change 2001 2000 Change Q4 Q4 12 Mon12 Mon Orders received 2 318 1 461 59% 8 376 5 243 60% Net sales 2 457 1 633 50% 8 148 5 254 55% EBITDA 474 329 44% 1 341 892 50% Operating profit 379 278 37% 974 697 40% Operating margin 15,4% 17,0% 12,0% 13,3% Profit before ta
Slide 29: Getinge AB Balance sheets
Getinge AB Balance sheets (Msek) Assets 2001-12-31 2000-12-31 Intangible fixed assets 2 768 2 451 Tangible fixed assets 1 341 1 228 Financial assets 462 391 Stock-in-trade 1 719 1 269 Current receivables 2 935 2 457 Liquid funds 364 235 Total assets 9 589 8 031 Shareholders' equity & liabilities Sha